A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses. [PDF]
Lu J+10 more
europepmc +1 more source
CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. [PDF]
Zhang L+14 more
europepmc +1 more source
Pathogen Spillover to an Invasive Tick Species: First Detection of Bourbon Virus in Haemaphysalis longicornis in the United States. [PDF]
Cumbie AN, Trimble RN, Eastwood G.
europepmc +1 more source
Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA [PDF]
Aaron C. Brault+7 more
core +1 more source
Suppression of Interferon Response and Antiviral Strategies of Bunyaviruses. [PDF]
He Y+6 more
europepmc +1 more source
N-glycosylation of viral glycoprotein is a novel determinant for the tropism and virulence of highly pathogenic tick-borne bunyaviruses. [PDF]
Shimojima M+8 more
europepmc +1 more source
Editorial: Tick-borne Bunyaviruses: an emerging public health threat. [PDF]
Hawman DW, Appelberg S, Duscher GG.
europepmc +1 more source
Rome City School District and Rome City School District Clerical Employees Unit, Oneida County Educational Local 869, CSEA, Local 1000, AFSCME, AFL-CIO (2001) [PDF]
core +1 more source
A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection. [PDF]
Ren X+13 more
europepmc +1 more source
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. [PDF]
Alkan C, O'Brien T, Kenyon V, Ikegami T.
europepmc +1 more source